不确定的潜力和心血管疾病的克隆造血:发病,临床表现,以及未来的方向
Saivaroon Gajagowni1, Steven Hopkins1, Yusuf Qadeer1
1Department of Medicine, Baylor College of Medicine, Houston, TX, United States of America.
Progress in cardiovascular diseases
|September 15, 2024
概括
不确定的潜力 (CHIP) 的克隆性血液形成现在与心血管疾病 (CVD) 有关. 这种双向关系意味着心血管疾病风险因素会影响CHIP,而CHIP会影响心血管疾病发病率和结果.
科学领域:
- 血液学 血液学 血液学
- 心脏病学 心脏病学
- 遗传学 遗传学 是一个
背景情况:
- 不确定潜力的克隆性血液形成 (CHIP) 是已知的血液恶性瘤的因素.
- 最近的大型队列研究和先进的基因分析揭示了CHIP和心血管疾病 (CVD) 之间的联系.
- CHIP和CVD之间的相互作用是双向的,受传统的CVD风险因素和CHIP对CVD自身影响的影响.
研究的目的:
- 审查CHIP与心脏病相关的流行病学.
- 为了确定与CHIP和CVD相关的风险因素.
- 探索CHIP在各种心血管疾病中的病原性.
主要方法:
- 最近研究的文献综述.
- 对大型队列数据的分析.
- 对遗传和分子机制的检查.
主要成果:
- 人们越来越认识到CHIP是心血管健康的重要因素.
- 传统的心血管疾病风险因素可能会加剧CHIP.
- CHIP对多种心血管疾病的发生和进展有影响.
结论:
- CHIP和CVD之间的联系是复杂的,双向的.
- 了解这种关系对于管理心血管风险至关重要.
- 进一步研究CHIP在心血管疾病的致病性是有必要的.
相关概念视频
Hematopoiesis
5.2K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.2K
Multipotency of Hematopoietic Stem Cells
3.0K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.0K
Lineage Commitment
3.0K
Commitment is the process whereby stem cells:
3.0K
Production of Formed Elements
1.3K
Hemangioblasts are multipotent stem cells originating from the mesoderm. They give rise to hematopoietic stem cells (HSCs), which undergo hematopoiesis to produce all the formed elements of blood. This process is regulated by a complex network of hematopoietic growth factors, including transcription factors, growth factors, and cytokines. These factors stimulate the HSCs to divide and differentiate, though some HSCs remain undifferentiated to maintain a self-renewing pool.
Most HSCs commit to...
Most HSCs commit to...
1.3K
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Overview of Hematopoiesis
3.8K
Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
3.8K


